
Dr. Matthew Schlenker
Matthew B. Schlenker is an Assistant Professor and University of Toronto Glaucoma, Cataract, & Anterior Segment surgeon at Kensington Eye Institute, Trillium Health Partners, and Toronto Western Hospital. He received his Bachelor’s Degree (Magna Cum Laude) in Economics from Yale University and then worked as a financial analyst at Bear Stearns and as a business analyst at McKinsey & Co. He received his MD (with Honours) and Ophthalmology training at the University of Toronto, where he was a Chief Resident. He then completed a Glaucoma and Advanced Anterior Segment Fellowship at Trillium Health Partners and a Master of Science in Epidemiology at the Harvard School of Public Health.
He is the Chair of Resident Research in the Department of Ophthalmology & Vision Sciences at U. of T. and sits on the Kensington Research Committee. He is a regular presenter at both local and international academic conferences and has published in Ophthalmology, American Journal of Ophthalmology, British Journal of Ophthalmology, Journal of Cataract and Refractive Surgery, among other journals.
Financial disclosure: Dr. Schlenker has/had an affiliation (financial or otherwise) with a commercial organization:
1.
Aeques
2.
Alcon
3.
Allergan
4.
Bausch
& Lomb
5.
Johnson
& Johnson
6.
Santen
7. Thea-Labtician
Sessions auxquelles Dr. Matthew Schlenker participe
Dimanche 22 Juin, 2025
To treat - Matt Schlenker / Not to treat - Steve Schendel
Sessions auxquelles Dr. Matthew Schlenker assiste
Dimanche 22 Juin, 2025
Join us in celebrating outstanding contributions to ophthalmology at the COS Awards of Excellence Ceremony. This special event will honor the recipients of the Paper and Poster Awards, recognizing their exceptional research and innovation. Paper award winners will be presented with their awards, while poster winners will have the opportunity to showcase their winning work.Author’s Name(s):
Author’s Name(s): Tianwei Ellen Zhou, David Mathew, Karen Wigg, Carmen Balian, Irfan Kherani, Matthew Schlenker, Jeremy SivakAuthor’s Disclosure Block: Tianwei Ellen Zhou, none; David Mathew, none; Karen Wigg, none; Carmen Balian, none; Irfan Kherani, none; Matthew Schlenker, none; Jeremy Sivak, noneAbstract BodyPurpose: Primary open-angle glaucoma (POAG) makes up 90% of glaucoma cases in developed countries and is associate...